Diabetes
Conditions
Interventions
Group C:Continuously wear the study medical device for 14 days
Group A:Continuously wear the study medical device for 14 days
Group B:Continuously wear the study medical device for 14 days
Sponsors
The Children's Hospital of Zhejiang University School of Medicine
Eligibility
Sex/Gender
All
Age
2 Years to 17 Years
Inclusion criteria
Inclusion criteria: 1. Aged between 2 years (including 2 years old) and 18 years (excluding 18 years old); 2. Clinical diagnosis of diabetes mellitus; 3. Be willing to wear the device continuously for 14 days, and collect blood to test the blood glucose value according to the requirements of this program; 4. Weight not less than 10.0kg; 5. Agree to participate in the clinical trial and sign informed consent.
Exclusion criteria
Exclusion criteria: 1. MRI is required during clinical trials; 2. Diffuse subcutaneous nodules; 3. Acute complications of diabetes; 4. Abnormal coagulation function (not coagulation too fast or too slow), the abnormal criteria are: (1) Activated partial thromboplastin time (APTT) was higher than 1.5 times the upper limit of normal, or lower than the lower limit of normal; (2) The prothrombin time (PT) was higher than 1.5 times the upper limit of normal value, or lower than the lower limit of normal value; 5. Participated in other clinical trials within 1 month; 6. Researchers think it is not suitable to be included in the group.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Accuracy; | — |
Countries
China
Contacts
Public ContactFu Junfen
The Children's Hospital of Zhejiang University School of Medicine
Outcome results
None listed